These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11283398)

  • 1. Health-related quality of life after stroke a comprehensive review.
    Tengs TO; Yu M; Luistro E
    Stroke; 2001 Apr; 32(4):964-72. PubMed ID: 11283398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One thousand health-related quality-of-life estimates.
    Tengs TO; Wallace A
    Med Care; 2000 Jun; 38(6):583-637. PubMed ID: 10843310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A meta-analysis of quality-of-life estimates for stroke.
    Tengs TO; Lin TH
    Pharmacoeconomics; 2003; 21(3):191-200. PubMed ID: 12558469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life and health economics: where is the link?
    Jönsson B
    Scand J Gastroenterol Suppl; 1996; 221():33-6. PubMed ID: 9110396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The burden of stroke in the Netherlands: estimating quality of life and costs for 1 year poststroke.
    van Eeden M; van Heugten C; van Mastrigt GA; van Mierlo M; Visser-Meily JM; Evers SM
    BMJ Open; 2015 Nov; 5(11):e008220. PubMed ID: 26614618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic Evaluation Plan (EEP) for A Very Early Rehabilitation Trial (AVERT): An international trial to compare the costs and cost-effectiveness of commencing out of bed standing and walking training (very early mobilization) within 24 h of stroke onset with usual stroke unit care.
    Sheppard L; Dewey H; Bernhardt J; Collier JM; Ellery F; Churilov L; Tay-Teo K; Wu O; Moodie M;
    Int J Stroke; 2016 Jun; 11(4):492-4. PubMed ID: 26936861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
    Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
    Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menopausal hormone therapy: a systematic review of cost-effectiveness evaluations.
    Velentzis LS; Salagame U; Canfell K
    BMC Health Serv Res; 2017 May; 17(1):326. PubMed ID: 28476121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced cutaneous malignant melanoma: a systematic review of economic and quality-of-life studies.
    Cashin RP; Lui P; Machado M; Hemels ME; Corey-Lisle PK; Einarson TR
    Value Health; 2008; 11(2):259-71. PubMed ID: 18380638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The usefulness of ratios for allocation decisions: the case of stroke.
    Ament A; Evers S; Baltussen R
    Cerebrovasc Dis; 2000; 10(4):283-8. PubMed ID: 10878433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are QALYs based on time trade-off comparable?--A systematic review of TTO methodologies.
    Arnesen T; Trommald M
    Health Econ; 2005 Jan; 14(1):39-53. PubMed ID: 15386674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An assessment of economic measures used in menorrhagia: a systematic review.
    Sanghera S; Frew E; Kai J; Gupta J; Elizabeth Roberts T
    Soc Sci Med; 2013 Dec; 98():149-53. PubMed ID: 24331893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How often do sensitivity analyses for economic parameters change cost-utility analysis conclusions?
    Schackman BR; Gold HT; Stone PW; Neumann PJ
    Pharmacoeconomics; 2004; 22(5):293-300. PubMed ID: 15061679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of health states after stroke: a systematic review of the literature.
    Post PN; Stiggelbout AM; Wakker PP
    Stroke; 2001 Jun; 32(6):1425-9. PubMed ID: 11387509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of Endovascular Stroke Therapy: A Patient Subgroup Analysis From a US Healthcare Perspective.
    Kunz WG; Hunink MG; Sommer WH; Beyer SE; Meinel FG; Dorn F; Wirth S; Reiser MF; Ertl-Wagner B; Thierfelder KM
    Stroke; 2016 Nov; 47(11):2797-2804. PubMed ID: 27758942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and methodologic rigor of quality-of-life assessments in the critical care literature.
    Heyland DK; Guyatt G; Cook DJ; Meade M; Juniper E; Cronin L; Gafni A
    Crit Care Med; 1998 Mar; 26(3):591-8. PubMed ID: 9504591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic analysis in dermatology.
    Ellis CN; Reiter KL; Wheeler JR; Fendrick AM
    J Am Acad Dermatol; 2002 Feb; 46(2):271-83. PubMed ID: 11807441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability of cost-effectiveness estimates for pharmaceuticals in Western Europe: lessons for inferring generalizability.
    Barbieri M; Drummond M; Willke R; Chancellor J; Jolain B; Towse A
    Value Health; 2005; 8(1):10-23. PubMed ID: 15841890
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.